Cell therapy (CT) developers face significant challenges across various stages of therapy development, including technology transfer, assay reproducibility, high costs, lengthy turnaround times, intricate workflows, and compliance with GMP guidelines. This infographic highlights the pivotal role of genetic analysis in CT development, from research and development to quality control, and demonstrates how integrated genetic technologies can help surmount these obstacles. Thermo Fisher Scientific offers reliable and innovative genetic technologies used at each stage, including next-generation sequencing (NGS), capillary electrophoresis (CE), real-time PCR (qPCR), digital PCR (dPCR), TaqMan gene expression assays and master mixes, and various software and service solutions.
Fill out the form below to download the interactive infographic.